Table 3.
Risk factors for clinical failure (rebleeding within 30 days after TAE)
| Univariate analysis | |||
| Variable | Success | Failure | p value |
| Cases included in analysis = 289 | 79.2% (229) | 20.8% (60) | |
| Age in yearsa | 62.3 ± 15.7 | 64.6 ± 14.9 | 0.313 |
| Sex (male) | 65.5% (150/229) | 66.7% (40/60) | 0.866 |
| ≥2 concomitant diseases | 41.0% (94/229) | 44.1% (26/59) | 0.675 |
| Hb level in mmol/la | 5.8 ± 1.3 | 5.3 ± 1.2 | *0.025 |
| FFPa | 0.2 ± 1.1 | 0.4 ± 1.8 | 0.444 |
| Red blood cell concentratesa | 1.9 ± 4.0 | 5.0 ± 10.4 | 0.061 |
| ≥6 units of red blood cell concentrates | 9.7% (22/227) | 25.4% (15/59) | *0.001 |
| No bleeding evidence (CT) | 23.0% (31/135) | 24.3% (9/37) | 0.862 |
| No bleeding evidence (DSA) | 2.2% (5/229) | 1.7% (1/60) | 1.000 |
| TAE during off-hours including weekends | 47.6% (109/229) | 60.0% (36/60) | 0.087 |
| Selective catheterization only | 19.2% (44/229) | 25.0% (15/60) | 0.322 |
| Sole use of coils for embolization | 52.4% (120/229) | 55.0% (33/60) | 0.720 |
| >1 vessel embolized | 11.8% (27/229) | 20.0% (12/60) | 0.098 |
| Anticoagulation | 31.0% (71/229) | 28.8% (17/59) | 0.745 |
| Corticosteroids | 7.4% (17/229) | 3.4% (2/59) | 0.382 |
| Shock | 14.4% (33/229) | 23.3% (14/60) | 0.095 |
| Coagulopathy | 16.8% (33/196) | 15.8% (9/57) | 0.852 |
| Referral from other hospital | 12.7% (29/229) | 25.0% (15/60) | *0.018 |
| Referral from ICU | 27.9% (64/229) | 39.0% (23/59) | 0.100 |